ST

Susan Teresa Noronha

Active Director Director DIN 02704190
DIN 02704190 First appointment Sep 2009 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 3 historical roles
Total affiliations 6 Since Sep 2009
Shareholding value •••• Premium profile

About Susan Teresa Noronha

Data last updated:

Susan Teresa Noronha is a Director at Africure Pharmaceuticals (India) Private Limited (since 2021), Director at Vs3 Golden Years Private Limited (since 2020) and Designated Partner at Pharma Inputs Llp (since 2016). The companies operate in Pharma and Travel and Hospitality. The largest current company by reported revenue is Africure Pharmaceuticals (India) Private Limited at ₹66.93 Cr (FY 2025). Earlier, Susan Teresa Noronha was a Director at Simrone Pharmaceutical Industries Limited (from 2012) and Whole-Time Director at Enormis Health Care Private Limited (from 2009) and 1 more.

DIN 02704190
Primary Designation Director
Industry Pharma
First Appointment 30 Sep 2009
Oldest Company Age 35 yrs
Largest company Africure Pharmaceuticals (India) Private Limited · ₹66.93 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Mar 20212017₹66.93 Cr (FY 2025)Active
Vs3 Golden Years Private Limited U74994MH2020PTC347308
Director06 Oct 20202020Active
Designated Partner17 Nov 20162016Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director20 Aug 20121991Strike Off
Enormis Health Care Private Limited U51900MH2000PTC127144
Whole-Time Director30 Sep 20092000Strike Off
Whole-Time Director30 Sep 20092000Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharma Inputs Llp
Simrone Pharmaceutical Industries Limited
Africure Pharmaceuticals (India) Private Limited
Enormis Health Care Private Limited
Premium access

Shareholding and investment profile for Susan Teresa Noronha

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Susan Teresa Noronha

Susan Teresa Noronha currently holds 3 directorships: Africure Pharmaceuticals (India) Private Limited (Director, since 26 Mar 2021, revenue ₹66.93 Cr (FY 2025)); Vs3 Golden Years Private Limited (Director, since 06 Oct 2020); Pharma Inputs Llp (Designated Partner, since 17 Nov 2016).

Susan Teresa Noronha was first appointed on 30 Sep 2009 as Whole-Time Director at Enormis Health Care Private Limited. The most recent appointment on record is 26 Mar 2021 at Africure Pharmaceuticals (India) Private Limited.

Susan Teresa Noronha held 3 earlier board appointments: Simrone Pharmaceutical Industries Limited (Director, from 20 Aug 2012); Enormis Health Care Private Limited (Whole-Time Director, from 30 Sep 2009); Megatis Pharmaceuticals Private Limited (Whole-Time Director, from 30 Sep 2009).

The current boards of Susan Teresa Noronha's companies include Ravi Shankar Chandrasekhar (Africure Pharmaceuticals (India) Private Limited), Sanskar Nawal Kumar Tated (Africure Pharmaceuticals (India) Private Limited), Simrone Noronha (Vs3 Golden Years Private Limited), Sinhue Bosco Noronha (Vs3 Golden Years Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available